甲状腺肿瘤的临床试验
总计108105个结果
-
Jena University HospitalGE Healthcare未知
-
Istituti Clinici Scientifici Maugeri SpAMerck Sharp & Dohme LLC招聘中
-
Genzyme, a Sanofi Company完全的分化型甲状腺癌美国, 瑞典, 巴西, 意大利, 波兰, 西班牙, 中国, 俄罗斯联邦, 法国, 日本, 丹麦, 捷克语
-
AstraZeneca终止
-
Huazhong University of Science and TechnologyChinese PLA General Hospital; West China Hospital; Tongji Hospital; The First Affiliated Hospital... 和其他合作者未知
-
Mashhad University of Medical SciencesPharmaceutical Research Center未知
-
M.D. Anderson Cancer Center招聘中
-
University of Texas Southwestern Medical CenterNovartis撤销
-
Thomas Jefferson University主动,不招人
-
Grupo Espanol de Tumores NeuroendocrinosGilead Sciences; MFAR尚未招聘
-
Memorial Sloan Kettering Cancer CenterAstraZeneca完全的
-
University of Colorado, Denver完全的
-
University Medical Center GroningenErasmus Medical Center完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis主动,不招人
-
Memorial Sloan Kettering Cancer Center完全的甲状腺癌,乳头状 | 甲状腺癌,滤泡性 | 甲状腺癌 | 甲状腺癌 | 甲状腺癌(滤泡细胞) | BRAF V600E 突变阳性美国
-
Medstar Health Research InstitutePfizer完全的
-
Seno Medical Instruments Inc.终止Feasibility Study for Thyroid Indication美国
-
Centre Francois BaclesseFondation avenir; laboratoire Genzyme完全的Thyroid Node | Indeterminate Cytology | Surgery Indication法国
-
University of PittsburghJohns Hopkins University; University of Colorado, Denver; University of Pennsylvania; University... 和其他合作者完全的